SURUNKALI BUYRAK KASALLIGINING DIALIZ BOSQICHIDAGI BEMORLARDA NOS3 GENI T786C POLIMORFIZMINING YURAK-QON TOMIR ASORATLARI BILAN BOG‘LIQLIGI
DOI:
https://doi.org/10.5281/zenodo.23367061Keywords:
surunkali buyrak kasalligi, dasturiy gemodializ, NOS3 T786C polimorfizmi, endotelial disfunksiya, genetik assotsiatsiya, yurak-qon tomir asoratlariAbstract
Surunkali buyrak kasalligining dializ bosqichida yurak-qon tomir asoratlari bemorlarning klinik holati va prognozini belgilovchi muhim muammolardan biridir. Ularning shakllanishida endotelial disfunksiya va irsiy omillar ishtirok etishi mumkin. Ushbu maqolada dasturiy gemodializ olayotgan bemorlarda endotelial azot oksidi sintazasini (eNOS) kodlovchi NOS3 genining T786C (rs2070744) polimorfizmi hamda uning yurak-qon tomir asoratlari mavjudligi bilan bog‘liqligi tahlil qilindi. 2024-2026-yillarda o‘tkazilgan tadqiqotda 90 nafar gemodializ bemori (asoratlarsiz 43 nafar, asoratlari mavjud 47 nafar) va 110 nafar sog‘lom nazorat ishtirokchisining genotiplari taqqoslandi. Qandli diabeti bo‘lgan bemorlar tadqiqotga kiritilmadi. Yurak-qon tomir asoratlari mavjud bemorlarda C allelining chastotasi 27,7%, asoratlarsiz bemorlarda esa 16,3% bo‘ldi (OR=1,97; 95% ishonch oralig‘i: 0,95- 4,08; p=0,067). CC genotipi mos ravishda 8,5% va 2,3% holatda aniqlandi. Kuzatilgan farqlar statistik ahamiyatlilik darajasiga yetmadi. Mazkur tadqiqot gemodializ sharoitida NOS3 genetik variantlarining tarqalishi haqida mahalliy ma’lumot beradi va ularni klinik-laborator ko‘rsatkichlar bilan birgalikda o‘rganish zarurligini ko‘rsatadi. Biroq polimorfizmning mustaqil prognostik ahamiyati tasdiqlanmadi.References
1. Jankowski, J., Floege, J., Fliser, D., Böhm, M., & Marx, N. (2021). Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options. Circulation, 143(11), 1157–1172. https://doi.org/10.1161/CIRCULATIONAHA.120.050686
2. Zoccali, C., Mallamaci, F., Adamczak, M., et al. (2023). Cardiovascular complications in chronic kidney disease: a review. Cardiovascular Research, 119(11), 2017–2032. https://doi.org/10.1093/cvr/cvad083
3. Eshmetova, S. I., & Jabbarov, O. O. (2026). Cardiovascular Complications in Dialysis. Eureka Journal of Health Sciences & Medical Innovation. 2026;2(2).
4. Roumeliotis, S., Mallamaci, F., & Zoccali, C. (2020). Endothelial Dysfunction in Chronic Kidney Disease, from Biology to Clinical Outcomes: A 2020 Update. Journal of Clinical Medicine. 2020;9(8):2359. DOI: 10.3390/ jcm9082359. https://doi.org/10.3390/
5. Baaten, C. C. F. (2023). M.J., Vondenhoff S., Noels H. Endothelial Cell Dysfunction and Increased Cardiovascular Risk in Patients With Chronic Kidney Disease. Circulation Research, 132(8), 970–992. https://doi.org/10.1161/
6. Nakayama, M., et al. (1999). T-786→C mutation in the 5-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation, 99(22), 2864–2870. https://doi.org/10.1161/01.CIR.99.22.2864
7. Yoshimura, M., et al. (2000). A T-786→C mutation in the 5-flanking region of the endothelial nitric oxide synthase gene and coronary arterial vasomotility. American Journal of Cardiology, 85(6), 710–714.
8. Marin-Medina, A., et al. (2023). Association between the Polymorphisms rs2070744, 4b/a and rs1799983 of the NOS3 Gene with Chronic Kidney Disease of Uncertain or Non-Traditional Etiology in Mexican Patients. Medicina. 2023;59(5):829. DOI: 10.3390/medicina59050829. https://doi.org/10.3390/medicina59050829
9. Sharapov, O. N., Daminov, B. T., & Yarygina, S. V. (2020). Cardiovascular pathologies in the urban population of the Republic of Uzbekistan with chronic kidney disease on hemodialysis. Kidneys. 2020;9(3). DOI: 10.22141/2307- 1257.9.3.2020.211459. https://doi.org/10.22141/2307-
10. Tursunova, L. D., & Jabbarov, O. O. (2023). Cardiorenal Syndrome in Patients with Chronic Kidney Disease and Diabetes Mellitus. American Journal of Pediatric Medicine and Health Sciences, 1(9), 332–339.
11. Jabbarov, A. A., & Tursunova, L. D. (2017). Narusheniy serdechno-sosudistoy sistemy u bolnykh, nakhodyashchikhsya na planovom gemodialize, i ikh ratsionalnaya korrektsiya. Evraziyskiy kardiologicheskiy zhurnal. 2017;(3).
12. Zakirova, G., Masharipova, D., Boboev, Q., & Tagaeva, D. (2026). T-786C Polymorphism of the NOS3 Gene and Its Role in the Development of Renal Dysfunction in Patients of the Uzbek Population with Chronic Heart Failure. Turk Kardiyol Dern Ars, 54(4), 310–315. https://doi.org/10.5543/tkda.2026.23779
13. Asakimori, Y., et al. (2004). Association between ENOS gene polymorphism and cardiovascular events in nondiabetic hemodialysis patients: a prospective study. American Journal of Kidney Diseases. 2004;44(1). DOI: 10.1053/j.ajkd.2004.03.034. https://doi.org/10.1053/j.ajkd.2004.03.034
14. Asakimori, Y., et al. (2002). T-786C polymorphism of the endothelial nitric oxide synthase gene influences the progression of renal disease. Nephron, 91(4), 747–751. https://doi.org/10.1159/000065041
15. Harlacher, E., Wollenhaupt, J., & Baaten, C. C. F. (2022). M.J., Noels H. Impact of Uremic Toxins on Endothelial Dysfunction in Chronic Kidney Disease: A Systematic Review. International Journal of Molecular Sciences. 2022;23(1):531. DOI: 10.3390/ijms23010531.

